The MoH recently announced a transition to Publicly Funded Shingrix® Vaccine for Ontario’s Shingles (Herpes Zoster) Immunization Program. Note, this is for patients between 65-70 years of age. Here is more information: OPDP SHINGRIX funded Oct 2020
Contributors
The ORA’s executive members are the core contributors to the newsletter. The ORA welcomes guest contributions to the newsletter from members-at-large and others in the rheumatology community.
